Tg Therapeutics (TGTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2009 | 12-2008 | 12-2007 | 12-2006 | 12-2005 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,793 | -4,269 | -12,032 | -9,695 | -19,141 |
| Depreciation Amortization | 549 | 65 | 48 | 60 | 54 |
| Other Working Capital | -219 | -972 | -3 | 208 | 1,039 |
| Other Operating Activity | 1,414 | 732 | 1,757 | 1,677 | 11,803 |
| Operating Cash Flow | $-1,050 | $-4,444 | $-10,230 | $-7,751 | $-6,245 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | 1,006 | 3,500 |
| PPE Investments | N/A | -9 | -9 | -37 | -40 |
| Net Acquisitions | N/A | N/A | N/A | N/A | 7 |
| Investing Cash Flow | $N/A | $-9 | $-9 | $969 | $3,467 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 1,032 | 3,759 | N/A | N/A | N/A |
| Debt Repayment | -43 | N/A | N/A | N/A | N/A |
| Common Stock Issued | N/A | 150 | 7,859 | -15 | 12,350 |
| Dividend Paid | N/A | N/A | N/A | N/A | -1 |
| Other Financing Activity | 0 | 0 | 0 | 0 | -650 |
| Financing Cash Flow | $989 | $3,909 | $7,859 | $-15 | $11,698 |
| Beginning Cash Position | 106 | 650 | 3,029 | 9,826 | 906 |
| End Cash Position | 45 | 106 | 650 | 3,029 | 9,826 |
| Net Cash Flow | $-61 | $-544 | $-2,379 | $-6,797 | $8,921 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,050 | -4,444 | -10,230 | -7,751 | -6,245 |
| Capital Expenditure | N/A | -9 | -9 | -37 | -40 |
| Free Cash Flow | -1,050 | -4,453 | -10,239 | -7,788 | -6,285 |